Annual report pursuant to Section 13 and 15(d)

CollabRx Acquisition (Details)

v3.2.0.727
CollabRx Acquisition (Details)
$ in Thousands
 12 Months Ended
Jul. 12, 2012
USD ($)
shares
Jul. 12, 2012
USD ($)
shares
Mar. 31, 2015
USD ($)
Advisor
shares
Mar. 31, 2014
USD ($)
Business Acquisition [Line Items]        
Business acquisition effective date     Jul. 12, 2012  
Acquisition agreement date     Jun. 29, 2012  
Percentage of interests acquired (in hundredths) 100.00% 100.00%    
Number of shares issuable to acquire business (in shares) | shares 236,433 236,433    
Shares issued specified as percentage of total shares outstanding (in hundredths) 14.00% 14.00%    
Interest rate on promissory note (in hundredths) 0.28% 0.28%    
RSUs and options granted as "inducement grants" to newly hired management (in shares) | shares     368,417  
Vesting period of equity awards     4 years  
Noncompetition period     3 years  
Stockholders Agreement Period of transfer restrictions and voting provisions     2 years  
Assets acquired [Abstract]        
Cash $ 476 $ 476    
AP and accrueds (333) (333)    
Deferred tax liability (664) (664)    
Goodwill 603 603 $ 603 $ 603
Total Acquired Assets, net 1,732 1,732    
Purchase Price summary [Abstract]        
Common Stock Consideration   932    
Promissory Note Assumed   500    
Loan Note Payable Assumed   300    
Total Purchase Price   1,732    
Number of clinical and scientific advisors | Advisor     50  
"Big data" opportunity value     $ 300,000,000  
Tax benefit recognized       $ 83
Developed Technology [Member]        
Assets acquired [Abstract]        
Intangible assets 720 720    
Customer Relationships [Member]        
Assets acquired [Abstract]        
Intangible assets 433 433    
Trade Name [Member]        
Assets acquired [Abstract]        
Intangible assets 346 346    
Non Compete Agreements [Member]        
Assets acquired [Abstract]        
Intangible assets $ 151 $ 151    
Restricted Stock Units (RSUs) [Member]        
Business Acquisition [Line Items]        
Aggregate RSUs forfeited (in shares) | shares     215,475